Endorsement consultation

03/11/2023
CL 01 Allianz - EFRAG DEA - Lack of exchangeability 2023.pdf
Comment Letter Received
07/12/2023
CL 02 GDV - EFRAG DEA - Lack of exchangeability 2023.pdf
Comment Letter Received
28/09/2023
DEA - Amendments to IAS 21 Lack of Exchangeability.pdf
Draft endorsement advice
09/01/2024
FEA - Amendments to IAS 21 Lack of Exchangeability - Endorsement advice letter to the EC.pdf
Endorsement Advice

Exposure draft consultation

15/07/2021
CL01 - ASCG_EFRAG_lack_of_exchangeability_210715_rev.pdf
Comment Letter Received
21/07/2021
CL02 - ESMA32-61-469 CL to EFRAG on IAS 21 amendments.pdf
Comment Letter Received
02/08/2021
CL03 - OIC CL on DCL EFRAG ED IAS 21 2021 08 02 .pdf
Comment Letter Received
24/08/2021
CL04 - ANC N° 37 -ED IAS21.pdf
Comment Letter Received
26/08/2021
CL05 - Acteo Afep Medef ED Lack of exchangeability .pdf
Comment Letter Received
31/08/2021
CL06 - DASC response EFRAG DCL to ED_2021_4 Lack of Exchangeability_310821.pdf
Comment Letter Received
02/09/2021
CL07 - ICAC´s comment on EFRAG DCL ED 2021 4.pdf
Comment Letter Received
02/09/2021
CL08 - BusinessEurope L090121EDLackofExchangeability.pdf
Comment Letter Received
02/09/2021
CL09 - IASB Consultation_ED-2021-4_Feedback Allianz Group to EFRAG.pdf
Comment Letter Received
14/09/2021
EFRAG Comment Letter - ED Lack of Exchangeability - 2021-09-14.pdf
Comment Letter
03/06/2021
EFRAG_Draft_Comment_Letter_-_Lack_of_Exchangeability.pdf
Draft comment letter
21/10/2021
Lack of Exchangeability - EFRAG Feedback statement on DCL.pdf
Feedback statement - comments received